Diabetes mellitus type2. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group1: People with type 2 diabetes, who in addition to medication, receive oral zinc in the amount of 220 mg zinc sulfate, three days a week for six months. Intervention
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Individual consent Diabetic Type 2 Proven by Metabolic Indicators (FBS and 2HBP) At least 3 years of diabetes history aged over 20
Exclusion criteria
Exclusion criteria: - Age over 60 Individual with a history of myocardial infarction Individual with hypermagnesemia Individual with hyperzincemia Patient with diabetic nephropathy Insulin Consumers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of hemoglobin A1c in people with type 2 diabetes. Timepoint: Measurement of hemoglobin A1c at baseline, 3 and 6 months after the start of the intervention. Method of measurement: Biochemical analysis by reference laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Peripheral neuropathy in patients with type 2 diabetes. Timepoint: Measurement of hemoglobin A1c at baseline, 3 and 6 months after the start of the intervention. Method of measurement: Michigan Neuropathy Survey Instrument(MNSI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReyhaneh Tabaraii
Ghoum University of Medical Sciences
Outcome results
None listed